all report title image

LUNG CANCER THERAPEUTICS MARKET ANALYSIS

Lung Cancer Therapeutics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

  • To Be Published : Nov 2024
  • Code : CMI702
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Regional Analysis

Higher carcinoma lung population dominates the lung cancer therapeutics market in North America

Regional segmentation of the lung cancer therapeutics market by Coherent Market Insights comprises North America, Europe, Asia-Pacific, Latin America and Middle East, and Africa. According to the American Cancer Society estimates of 2017, approximately 195,000 people are suffering from NSCLC every year in the U.S. where, the number of deaths from NSCLC is recorded to be around 135,000, thus increasing the demand for lung cancer therapeutics in North America. The increasing demand in North America is also due to rising prevalence of lung cancer, increasing geriatric population, high smoking habits leading to higher carcinoma lung population. Asia Pacific is projected a higher growth rate in the forecast period owing to the growing awareness of enhanced health care, Government funding, and the presence of medical requirements for cancer therapeutics in the developing economies of India and China.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.